s*****r
发帖数: 11545 | 1 http://www.usatoday.com/story/money/business/2013/10/01/merck-l
Drug maker Merck says it will slash thousands of jobs and move its
corporate headquarters to save money.
AP Earns Merck
(Photo: Matt Rourke, AP)
Story Highlights
Merck plans to cut up to 8,500 jobs
That's in addition to the 7,500 job cuts previously announced
The drug maker also plans to move its headquarters
SHARE 627 CONNECT 85 TWEET 48 COMMENTEMAILMORE
Bruce Horovitz, USA TODAY 12:50 p.m. EDT October 1, 2013
Drug maker Merck announced Tuesday that it will lay off thousands of
employees as it streamlines its research and development and other functions.
In a news release, the company says the job cuts of about 8,500 are part of
"a global initiative to sharpen its commercial and research and development
(R&D) focus."
Merck, based in Whitehouse Station, N.J., expects to save about $2.5 billion
in annual net costs by the end of 2015. It expects to realize $1 billion of
those savings by the end of 2014.
For Merck, it's job cuts on top of job cuts. The 8,500 jobs to be eliminated
are in addition to the 7,500 positions Merck already has announced, the
company said in its news release.
"These actions will make Merck a more competitive company, better positioned
to drive innovation and to more effectively commercialize medicines and
vaccines for the people who need them," said Kenneth C. Frazier, chairman
and chief executive officer, in a statement. "Today's announcement further
underscores that we are committed to improving our performance in the short
term while also investing for the long term to create value for patients,
customers and shareholders."
The overhaul is part of a broader strategy being set by the company's R&D
chief Roger Perlmutter. Frazier hired Perlmutter in April as a replacement
for Peter Kim, following developmental setbacks for experimental drugs in
cardiovascular, surgery and osteoporosis.
The company also said, on Tuesday, in a separate news release, that it will
move its global headquarters from Whitehouse Station to its existing
facilities in Kenilworth, N.J. The company had previously announced that it
would close its Whitehouse Station building and relocate its global
headquarters to Summit, N.J.
But after re-evaluating its real estate needs in the state, Merck determined
that it could achieve greater cost savings and operational synergies by
closing both its Summit campus and its main Whitehouse facility, according
to the Merck release.
The transition is expected to begin next year and be completed in 2015.
Merck has been headquartered in Whitehouse Station since 1992, and before
that was headquartered in Rahway, N.J. | c****g
发帖数: 37081 | | T**********e
发帖数: 29576 | 3 制药界经过好几次大变动，70-80年代前主要是大化工厂的副业，90年代后形成了现在
研发为主的大药厂模式，现在这些大药厂除了少数几个，研发模式都失败了，自己搞不
出blockbuster，他们势必要把20年积累的庞大研发人员裁掉。 | p********7
发帖数: 18007 | 4 药物研发的路子是扯淡，没戏
【在 T**********e 的大作中提到】
: 制药界经过好几次大变动，70-80年代前主要是大化工厂的副业，90年代后形成了现在
: 研发为主的大药厂模式，现在这些大药厂除了少数几个，研发模式都失败了，自己搞不
: 出blockbuster，他们势必要把20年积累的庞大研发人员裁掉。
| s*****r
发帖数: 11545 | 5 药物研发的路子是 merger, acquisition, and layoff... concisely, capital
manipulation. | s*****e
发帖数: 16824 | 6 主要还是现在药物研发越来越难，风险越来越大，所以大公司都想办法转移风险，让小
公司搞研发。小公司研发成了，就买，不成，小公司就破产，损失转嫁给股东和债主了
。大公司自己搞研发，不成，又不能破产，只能把损失全部吃进，很不划算。
【在 s*****r 的大作中提到】
: 药物研发的路子是 merger, acquisition, and layoff... concisely, capital
: manipulation.
| s*****r
发帖数: 11545 | 7 why is pfizer no. 1? because it has seen this business pattern before the
acquisition of Warner-lambert and has steadily practiced it ever since.
Management in lili rejected this model... very ambitious, arrogant, and
redneck. Unfortunately, research is not their top priority either. They
started considering pfizer model when they acquired imclone, yet denied the
strategy with pretenses. The transaction turned out to be a failure. That is
why lili will go to hell.
【在 s*****e 的大作中提到】
: 主要还是现在药物研发越来越难，风险越来越大，所以大公司都想办法转移风险，让小
: 公司搞研发。小公司研发成了，就买，不成，小公司就破产，损失转嫁给股东和债主了
: 。大公司自己搞研发，不成，又不能破产，只能把损失全部吃进，很不划算。
| l********o
发帖数: 5629 | 8 Lilly好像是很差的样子。
我认识里面一个老中，整天无所事事，就是跑步，说很无聊。
the
is
【在 s*****r 的大作中提到】
: why is pfizer no. 1? because it has seen this business pattern before the
: acquisition of Warner-lambert and has steadily practiced it ever since.
: Management in lili rejected this model... very ambitious, arrogant, and
: redneck. Unfortunately, research is not their top priority either. They
: started considering pfizer model when they acquired imclone, yet denied the
: strategy with pretenses. The transaction turned out to be a failure. That is
: why lili will go to hell.
|
|
